We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWFG
3151
TWFG Inc
TWFG
$1.43B
$23.5K ﹤0.01%
+865
New +$22.4K
REAX icon
3152
Real Brokerage
REAX
$549M
$23.4K ﹤0.01%
+4,225
New +$24K
RBCAA icon
3153
Republic Bancorp
RBCAA
$1.93B
$23.4K ﹤0.01%
359
-1,286
-78% -$78.7K
INFA
3154
DELISTED
Informatica
INFA
$23.4K ﹤0.01%
926
-23,485
-96% -$595K
STER
3155
DELISTED
Sterling Check Corp. Common Stock
STER
$23.4K ﹤0.01%
1,398
-3,293
-70% -$52.2K
AFCG
3156
AFC Gamma
AFCG
$70M
$23.3K ﹤0.01%
2,281
-8,573
-79% -$82.9K
FTGC icon
3157
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.08B
$23.3K ﹤0.01%
983
+900
+1,084% +$20.9K
NKTR icon
3158
Nektar Therapeutics
NKTR
$2.52B
$23.2K ﹤0.01%
1,192
+577
+94% +$11K
IMMR icon
3159
Immersion
IMMR
$249M
$23.2K ﹤0.01%
2,597
-1,047
-29% -$10.7K
QTRX icon
3160
Quanterix
QTRX
$126M
$23.2K ﹤0.01%
1,787
-4,471
-71% -$59.7K
DBP icon
3161
Invesco DB Precious Metals Fund
DBP
$258M
$23.2K ﹤0.01%
363
GPCR icon
3162
Structure Therapeutics
GPCR
$3.82B
$23.1K ﹤0.01%
527
+158
+43% +$6.11K
CRNX icon
3163
Crinetics Pharmaceuticals
CRNX
$8.98B
$23.1K ﹤0.01%
452
-12,404
-96% -$640K
ATHM icon
3164
Autohome
ATHM
$2.62B
$23.1K ﹤0.01%
+708
New +$18.5K
BETR icon
3165
Better Home & Finance Holding
BETR
$20.5M
$23K ﹤0.01%
+1,294
New +$27.5K
DFTX
3166
Definium Therapeutics
DFTX
$5.81B
$23K ﹤0.01%
4,045
+1,027
+34% +$7.14K
ORGO icon
3167
Organogenesis Holdings
ORGO
$225M
$22.9K ﹤0.01%
8,021
-1,530
-16% -$4.29K
ZIMV
3168
DELISTED
ZimVie
ZIMV
$22.8K ﹤0.01%
1,434
-3,545
-71% -$63.6K
IVR icon
3169
Invesco Mortgage Capital
IVR
$812M
$22.8K ﹤0.01%
2,423
-2,914
-55% -$26.2K
DOUG icon
3170
Douglas Elliman
DOUG
$181M
$22.7K ﹤0.01%
12,422
-29,235
-70% -$50.1K
EU
3171
enCore Energy
EU
$231M
$22.7K ﹤0.01%
5,624
-18,898
-77% -$70K
LOCO icon
3172
El Pollo Loco
LOCO
$471M
$22.7K ﹤0.01%
1,657
-4,238
-72% -$53.1K
URGN icon
3173
UroGen Pharma
URGN
$2.31B
$22.6K ﹤0.01%
1,778
-1,590
-47% -$23.6K
WHD icon
3174
Cactus
WHD
$5.92B
$22.6K ﹤0.01%
378
-5,791
-94% -$337K
AXIA
3175
DELISTED
AXIA Energia
AXIA
$22.5K ﹤0.01%
3,938
-4,752
-55% -$27.1K

Similar funds

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.